A recent blood-based hepatitis C virus assay on Nuclein's DASH system highlighted its on-device sample prep, among other features that have been driving its adoption.

Shanx Medtech BV raised €15 million (US$17.5 million) in a seed funding round for its in vitro diagnostic platform for ultra-rapid antimicrobial susceptibility testing. The financing came from a range ...

A rapid Avian influenza molecular test, detecting the latest H5N1 variants in cattle and the recent human inflections in Colorado, is now available to fight bird flu. The rapid test is the latest ...

MONTREAL--(BUSINESS WIRE)--Avitia, an AI company providing end-to-end testing solutions to rapidly identify cancer mutations and applicable treatments, today announced its business launch and $5M seed ...

The ongoing AI boom is transforming the online user experience (UX) at a rapid pace, and the development of automation technology is redefining usability testing. The global AI-enabled testing market ...

SAN MATEO, Calif.--(BUSINESS WIRE)--RapidAI, the world leader in AI-driven medical imaging analysis and coordinated care, today announced the launch of its Rapid Enterprise™ Platform, powered by Rapid ...

Northwestern scientists have created the fastest-ever hepatitis C diagnostic, delivering accurate results in only 15 minutes. The test uses the DASH rapid PCR system, originally developed for COVID, ...

Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented ...

Co-Diagnostics receives Australian patent covering Co-Dx PCR platform technologies for nucleic acid detection and analysis: Salt Lake City Wednesday, December 31, 2025, 11:00 Hrs ...